Sort   by:  
 Page size 
UnknownPARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.
Not available
S-EPMC6599836 | biostudies-literature
UnknownNeoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study.
Not available
S-EPMC9879000 | biostudies-literature
UnknownMetastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review.
Not available
S-EPMC5836187 | biostudies-literature
UnknownExpression of antibody-drug conjugate targets in soft tissue sarcomas.
Not available
S-EPMC12528890 | biostudies-literature
UnknownComparative genomic analysis of primary tumors and metastases in breast cancer.
Not available
S-EPMC5053643 | biostudies-literature
UnknownSimilar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.
Not available
S-EPMC5630389 | biostudies-literature
UnknownSafety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.
Not available
S-EPMC6192912 | biostudies-literature
UnknownNOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Not available
S-EPMC7053236 | biostudies-literature
UnknownMetastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
Not available
S-EPMC8327489 | biostudies-literature
UnknownProspective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Not available
S-EPMC8132379 | biostudies-literature
Sort   by:  
 Page size